All In MedTech

Device Trial Radar · NCT05839873

Abbott Ventricular Tachycardia PAS

Abbott Ventricular Tachycardia Post Approval Study

Last checked: Nov 19, 2026Latest source record: Oct 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

62

Actual

Start

Jul 24, 2023

Primary completion

Aug 2026

Study completion Nov 2026

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
May 3, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 7 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This post-approval study (PAS) is designed to provide continued clinical evidence to confirm the long-term safety and effectiveness of the FlexAbilityTM Ablation Catheter, Sensor EnabledTM (FlexAbility SE) for the treatment of ventricular tachycardia in a post-market environment. This is a prospective, single arm, open-label, multi-center, observational study.

Conditions

  • Ventricular Tachycardia

Interventions

  • FlexAbility SE Ablation CatheterDevice

    Subjects receive ablation treatment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of study device- and/or Study Ablation Procedure-related SAEs through 12 months post Index Ablation Procedure.Time frame: 12 Month
  2. Composite of 12-month freedom from VT recurrence, death, and cardiac transplantationTime frame: 12 Month

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • NCH Healthcare System

    Naples, Florida

  • St. Vincent Hospital

    Indianapolis, Indiana

  • Kansas City Cardiac Arrhythmia Research Foundation

    Overland Park, Kansas

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.